|By Business Wire||
|March 18, 2014 07:00 AM EDT||
MedCurrent Corporation (“MedCurrent”), a leading provider of clinical decision support solutions (CDS), announced the appointment of Anthony F. Griffiths, M.B.A.; Robert David Henry, J.D., and Arun Menawat, M.B.A., Ph.D. to its Board of Directors.
“The addition of these three Directors, brings a new depth of financial, scientific and operational experience to MedCurrent.” said Dr. Brent Norton, President of MedCurrent. “Our company is growing rapidly with additional contracts for our OrderRightTM CDS system as well as the expansion of our OrderRightTM platform, their expertise will be invaluable to us over the next many years.”
Anthony Griffiths brings a wealth of business and financial capabilities to MedCurrent’s board. Mr. Griffiths currently serves on several other boards, including Fairfax Financial Holdings Limited, Novadaq Technologies, Inc., and Blue Ant Media. His operational experience includes leading such notable companies such as Mitel Corporation, where he was the Chairman, President and CEO. He has also held board positions with AbitibiBowater Inc., Bronco Energy Limited, and Alliance Atlantis Communications Inc. Mr. Griffith has a B.A. degree from McGill University, Canada, and an M.B.A. from The Harvard Graduate School of Business.
Robert Henry brings his legal and business insights to MedCurrent’s board, with business skills honed as a successful owner/operator of an international apparel importing, distribution and consulting business as well as board experience with Stedfast Inc. Mr. Henry is a graduate of Osgoode Hall Law School, at York University, and is a member of the Law Society of Upper Canada.
Dr. Arun Menawat brings his extensive business experience and scientific acumen to MedCurrent’s board. Dr. Menawat is currently the President and Chief Executive Officer of NOVADAQ technologies (NASDAQ:NVDQ; TMX: NDQ), a provider of SPY fluorescence technologies, and previously was the President and COO of Cedara Software (acquired by Merge Healthcare (NASDAQ: MRGE) in 2005). Dr. Menawat earned an Executive M.B.A. from the J.L. Kellogg School of Management, Northwestern University, and a Ph.D. and M.S. in Chemical Engineering from the University of Maryland.
For further information, visit www.medcurrent.com.
About MedCurrent Corporation
MedCurrent (www.medcurrent.com) develops medical appropriateness decision support systems that provide information to physicians at the point of care to facilitate their ordering of the most medically appropriate procedures. Using rule criteria adopted by leading clinical associations, as well as tools for organizations to create their own rules, these solutions help health care payers and providers improve patient care, avoid unnecessary procedures, reduce inappropriate utilization and unnecessary radiation exposure, and mitigate costs. The company sells direct to payers, providers and partners including EMR, HIS or PHR vendors.
MedCurrent’s first specialty product, OrderRightTM for Radiology, provides patient-specific appropriate imaging information to ordering physicians to guide them in their imaging choices for their patients. OrderRightTM shortens waiting times and reduces costs for high-tech imaging procedures (e.g. CT, MRI, PET), and reduces the total amount of radiation that a patient receives over their lifetime. MedCurrent has started with radiology, but the system is designed to be extensible to manage clinical appropriateness for any medical specialty.